New publication on CRP apheresis as a therapeutic option in STEMI

11.07.2023

The cardiac MRI tissue characteristics of myocardial damage correlate with the extent of left ventricular dysfunction in the acute phase of severe myocardial infarction (STEMI). Since lowering CRP levels leads to smaller infarcts and better heart function, it could be considered as an additional therapeutic option in STEMI.

You can find the publication entitled Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance here.